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Abstract
Reports of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) causing hospital infections are increasing, and it is
questionable whether the existing molecular deﬁnition of CA-MRSA is suitable for the characterization of all strains involved. The 821
methicillin-resistant S. aureus (MRSA) isolates recovered from patients in Health Region East, Norway during the period 1991–2006
were characterized by multilocus sequence typing (MLST), staphylococcal cassette chromosome mec (SCCmec) typing, staphylococcal
protein A (spa) gene typing, and their content of exotoxin-encoding genes. Cluster analysis based on exotoxin-encoding gene content
was performed to separate the MRSA isolates into valid clusters with respect to microbiological characteristics. The analysis gave a
four-cluster structure, and the four toxin clusters differed in the genetic lineages they included and in the diversity of the genetic lin-
eages. A few genetic lineages were present in several toxin clusters. These results support the theory that mobile genetic elements
encoding virulence genes do not move randomly among genetic lineages, but are restricted by the clonal lineages’ genetic background.
Using the molecular criteria, MLST type, SCCmec type and the presence of the lucS/F-Panton–Valentine leukocidin (PVL) gene to deﬁne
a CA-MRSA isolate, it was found that the CA-MRSA isolates mainly grouped together in two toxin clusters with a low prevalence of
exotoxin-encoding genes. Statistical analyses supported the conclusion that toxin clusters with CA-MRSA genetic lineages were charac-
terized by a low prevalence of exotoxin-encoding genes, whereas toxin clusters with hospital-acquired MRSA genetic lineages were
characterized by a higher prevalence of exotoxin-encoding genes.
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Introduction
Community-acquired methicillin-resistant Staphylococcus aur-
eus (CA-MRSA) strains have been found to differ genetically
from hospital-acquired MRSA (HA-MRSA) strains in three
major genotypic markers: their genetic lineage, the staphylo-
coccal cassette chromosome mec (SCCmec) type, and
the presence of the lucS/F-Panton–Valentine leukocidin genes
(PVL) [1]. The CA-MRSA strains are reported to have a
more diverse genetic background than HA-MRSA strains
[2,3]. Some strains are closely related to HA-MRSA, but
most have genetic characteristics not found in HA-MRSA [4].
Distinguishing CA-MRSA from HA-MRSA on epidemiological
grounds may be difﬁcult, as detailed information on the
patient’s background and medical history has to be obtained.
Deﬁning methicillin-resistant S. aureus (MRSA) as commu-
nity-acquired on the basis of the isolate’s genetic content has
been proposed as an alternative to the use of epidemiologi-
cal criteria, and the molecular markers used are the genetic
lineage, the SCCmec type, and the presence of the lucS/F-
PVL genes. The prevalence of MRSA meeting the molecular
criteria for being community-acquired is increasing inside
hospitals, and MRSA strains not meeting the criteria are
appearing in community infections, raising the question of
whether there is a need for other or additional molecular
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markers. There are reasons to believe that the selection
pressures acting on the clones in the hospital environment
are different from those prevailing in the community. Viru-
lence-associated genetic elements might be affected differ-
ently, and it has been suggested that CA-MRSA and HA-
MRSA differ in other parts of their exotoxin-encoding gene
content [5]. In this study, we addressed the question of
whether the exotoxin-encoding gene content could separate
MRSA isolates into relevant groups or clusters.
We have a complete record of people infected with MRSA
in the largest health region in Norway during the period 1991–
2006, and the MRSA isolates obtained from these patients.
The MRSA isolates have been characterized by sequence type
(ST), SCCmec type, staphylococcal protein A type, and the
presence or absence of several exotoxin-encoding genes. The
epidemiological data available are limited to the information
that accompanied the specimens to the laboratories.
Materials and Methods
Study population and bacterial isolates
This study was population-based and bi-directional, retrospec-
tive from 1991 to 2004 and prospective from 2005 to 2006,
and included all people diagnosed with MRSA in Health Region
East, a region covering 35% of the Norwegian population.
One MRSA isolate per person was included, except when
several genetically distinct isolates had been obtained, in which
case one isolate from each genotype was selected. The isolates
were obtained from six microbiology laboratories.
MRSA identiﬁcation and DNA isolation
All MRSA isolates were identiﬁed by growth on Mueller–Hin-
ton agar containing 2% NaCl, 4 mg/L oxacillin and 8 mg/L
aztreonam for 2 days, or by growth on chromID MRSA
according to the manufacturer’s instructions (bioMe´rieux SA,
Marcy l’Etoile, France). The isolates were tested for oxacillin
susceptibility by E-test (AB Biodisk, Solna, Sweden), and for
the presence of the genes mecA and SA442 using light cycler
PCR and Roche light cycler system-PCR (Roche Applied
Science, Indianapolis, IN, USA) [6]. Total DNA was isolated
as described previously [7].
Multilocus sequence typing and BURST analysis
Multilocus sequence typing was performed by a modiﬁcation
of the protocol of Enright et al. [7,8].
The relationship between the STs was analysed using the
clustering algorithm eBURST v/3 [9] (http://eburst.mlst.net),
employing the group deﬁnition of similarity at six of seven loci;
that is, members of a group might differ at a single locus.
SCCmec typing
SCCmec typing was performed by identifying the ccr and mec
complexes. For SCCmec types I–IV, the typing was
performed as described previously [7]. For SCCmec type V,
the primers used for identiﬁcation of the class C2 mec com-
plex were IS-2 and mA2 [3], and those used for the ccrC
complex were cF and cR [10]. These primers and the PCR
conditions are described in Appendix S1.
Staphylococcal protein A (spa) typing and BURP analysis
Spa typing was performed by sequencing of the variable X
region at the 3¢-end of the spa gene, as described previously
[7]. Spa types and BURP spa clonal complexes (spa-CCs)
[11] were assigned using Ridom StaphType software v/1.5.5,
situated on the SpaServer Typing website (http://spaserver.
ridom.de/) [12]. The calculated cost among members of a
group in this study was set to be less than or equal to four.
Spa types shorter than ﬁve repeats were excluded from the
analysis because no reliable deduction about ancestries could
be made.
Exotoxin-encoding genes
The presence of genes coding for PVL (lucS/F-PVL), eight
staphylococcal enterotoxins (sea, seb, sec, sed, see, seg, sei,
and sej), three exfoliative toxins (eta, etb, and etd), an epider-
mal cell differentiation inhibitor (edin-B), toxic shock syn-
drome-1 (tst) and a-haemolysin (hla) was determined. The
detection of staphylococcal enterotoxin genes, eta, etb, tst
and lucS/F-PVL [13] was performed using real-time PCR and
power SYBR Green master mix, according to the manufac-
turer’s instructions (Applied Biosystems, Foster City, CA,
USA). The detection of hla [14] and etd and edin-B [15] was
performed by conventional PCR. The primers and the PCR
conditions are described in Appendix S1.
Reference strains
The reference strains used were FRI913 (sea, sec, see, and
hla), FRI1151m (sed and sej), RN4850 (eta and etb), 31844
(etd and edin-B) (in-house strain), CCUG2354 (tst),
CCUG25924 (seb), CCUG47167 (seg, sei, and lukS/F-PVL),
COL (SCCmecI), BK2464 (SCCmecII), ANS46 (SCCmecIII),
44110 (SCCmecIV) (in-house strain), and WIS (SCCmecV).
Strains FRI913, FRI1151m, RN4850, COL, BK2464 and
ANS46 were kindly provided by J. Etienne (Lyon, France).
Strain WIS was kindly provided by T. Ito (Juntendo, Japan).
Splitting of database
To avoid the undesirable situation where hypotheses are
derived after data have been seen, we used a data-splitting
approach [16]. The MRSA database was randomly split into
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two approximately equal parts after stratifying the entire
dataset by the following three variables: age when infected,
type of infection, and body site from which the bacterial
sample was taken. One part of the data was used for identi-
fying hypotheses, while the investigators remained blind to
the second part. The second part was used for hypothesis
testing. For the supported hypotheses, the entire dataset
was used to obtain the ﬁnal estimates.
All statistical analyses were performed following the data-
splitting approach.
Statistical analyses
Statistical analyses were performed using SPSS v/15 for Win-
dows and Microsoft Ofﬁce Excel for Windows 2000.
To ﬁnd possible microbiological characteristics that would
divide isolates into relevant categories, cluster analysis based
on the presence of the exotoxin-encoding genes lukS/F-PVL,
sea-see, seg, sei-sej, eta, etb, etd, tst and hla in the MRSA iso-
lates was performed. Edin-B was not used, as it occurred in
association with etd. We applied hierarchical cluster analysis
[17], where a dissimilarity matrix was computed using
squared Euclidean distance, and clustering was performed by
Ward’s method [18]. Comparison of identiﬁed toxin clusters
was performed using a chi-square test. A signiﬁcance level of
5% was chosen.
Research ethics
The collection and analysis of data were approved by the
Norwegian Social Science Data Services. The Regional Com-
mittee for Medical Research Ethics, Eastern Norway,
approved the execution of the project as it was described in
the application.
Results
Eight hundred and twenty-one people were infected or colo-
nized with MRSA in the time period studied: 454 infections/
colonizations were detected in healthcare institutions, 363
were detected outside such institutions, and for four people
this information could not be retrieved.
MRSA genetic lineages
Several genetic lineages were found in the MRSA database
(Table 1). Thirty-one spa types were not placed in a spa-CC
by the BURP analysis. Seventeen were excluded because of
short sequences, 12 were singletons, and two types were
found to be related, although no founder could be predicted.
For one MRSA isolate, the spa type could not be identiﬁed.
Nine MRSA isolates were not of SCCmec type I–V: three
were non-typeable, and in six isolates only one of the com-
plexes was found.
Cluster analysis
Frequency analysis on the exotoxin-encoding gene content
resulted in exclusion of two genes, see (not detected) and
etb (present in only one isolate), from the cluster analysis,
which was performed on the remaining 12 genes, and
resulted in a four-cluster structure. The distributions of the
exotoxin-encoding genes in the four clusters were found to
be signiﬁcantly different (p <0.001) (Table 2).
TABLE 1. Methicillin-resistant Staphylococcus aureus (MRSA)
genetic lineages (deﬁned by clonal complex (CC), sequence
type (ST), staphylococcal cassette chromosome mec
(SCCmec) type, and spa-CC) encountered in the MRSA
database of Akershus University Hospital Trust, covering
Health Region East, Norway, during the period 1991–2006
CCa (n) Spa-CCb (n) ST-SCCmecc
1 (11) 127 (9) 1-IV, 474-V, 891-IV, 993-IV
S (2) 1-IV, 772-V
5 (114) 002 (107) 5-I, 5-II, 5-IV, 5-V, 105-II, 114-II,
125-IV, 146-IV, 149-IV, 225-II,
231-II, 823-II, 826-IV, 998-IV
062 (5) 5-I, 5-II, 5-IV
E (2) 5-IV
8 (324) 008 (245) 8-IV, 8-V, 8-mecA, 8-C2mec, 94-IV,
112-I, 113-IV, 247-I, 254-I, 449-IV,
824-I, 995-IV, 999-IV
012 (70) 110-mecA, 239-III, 241-III,
368-III, 592-III, 996-III
148 (8) 72-IV, 72-V
S (1) 72-IV
9 (1) S (1) 834-IV
12 (5) 160 (5) 12-IV
15 (1) S (1) 15-ccrC
22 (39) 022/032 (38) 22-IV
E (1) 22-IV
30 (77) 012 (70) 30-IV, 30-V, 36-II, 37-IV
S (4) 30-IV, 39-II
E (3) 30-IV
45 (72) 065 (9) 45-IV
216 (1) 45-IV
015/116 (35) 45-IV, 820-IV
722/102 (18) 45-IV, 108-IV, 882-IV
E (9) 45-IV, 45-ccrC, 45-NT, 46-IV
59 (20) 216 (20) 59-IV, 59-V, 338-V, 375-IV
80 (108) 639 (106) 80-IV, 822-IV, 994-IV, 997-IV
E (1) 80-IV
NT (1) 80-IV
88 (22) 186 (22) 88-IV, 825-IV, 859-IV
97 (1) S (1) 97-IV
228 (6) 002 (6) 111-I, 228-I
398 (1) S (1) 398-V
509 (1) S (1) 207-V
913 (1) E (1) 913-V
d140 (2) NF (2) 140-IV
d152 (14) 355 (14) 152-V
d154 (1) 639 (1) 154-IV
aFor ST140, ST152, and ST154, no predicted founder could be established using
eBURST v/3.
bS, singleton (no related spa type could be found using BURP); E, excluded (the
spa sequence contained fewer than ﬁve repeats and was excluded from the
BURP analyses); NF, related spa types, but no predicted founder could be found
using BURP; NT, non-typeable.
cC2mec, only the C2 mec complex could be found; mecA, only the mec-
complex A could be found; ccrC, only the ccr complex C could be found; NT,
non-typeable.
CMI Fossum Moen et al. Exotoxin-encoding gene content in HA-MRSA and CA-MRSA 1141
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15, 1139–1145
Toxin clusters and genetic lineages
The four clusters were found to be different with regard to
both the presence of genetic lineages (clonal complex (CC),
ST, SCCmec type, spa-CC) and the diversity of the lineages
(Table 3). Cluster I was the most heterogeneous cluster and
cluster III the second most heterogeneous; clusters II and IV
consisted of isolates belonging solely to one CC (Table 3).
Exotoxin-encoding genes and genetic lineages
Exotoxin-encoding genes are known to have different distri-
butions within and among genetic lineages. The exotoxin-
encoding gene distribution within the CCs in this study is
shown in Table 4. Seven isolates belonging to CC45, ST45-IV
and spa-CC722/102 contained sej but not sed, despite the
two genes being located on the same plasmid. One reason
for this result might be that the primers used for detection
of sed were not able to attach to the template in this clone.
LukS/F-PVL, known as a marker for CA-MRSA, was found
in all toxin clusters (Table 2).
Discussion
The cluster analysis produced four toxin groups (clusters I–IV)
that differed signiﬁcantly in their exotoxin-encoding gene dis-
tribution.
Toxin clusters II and IV were homogeneous, both in their
genetic lineage and in their exotoxin-encoding gene content.
Among the 17 CCs discovered in the database, only ﬁve
were found in more than one cluster. Four of these ﬁve
were found in two clusters, and one, CC8, was found in
three clusters. The CCs appearing in two clusters had a dif-
ferent distribution of isolates between the clusters: one clus-
ter contained one isolate, and the second cluster contained
the remaining isolates. These results indicate that the genetic
lineages, with the exception of CC8, correlate well with the
toxin clusters, and support the theory that mobile genetic
elements (MGEs) encoding virulence genes do not move
randomly among genetic lineages, but are restricted by the
clonal lineages’ genetic backgrounds [19,20]. CC8 was found
in three clusters and had a different distribution among the
clusters. Cluster III contained a few isolates, whereas clus-
ters I and II contained 204 and 110 isolates, respectively.
Only two of the 17 STs, ST8 and ST239, appeared in several
clusters. ST8 appeared in clusters I and II, and ST239 in clus-
ters I and III. The distribution among several clusters
indicates that this genetic lineage is diverse in its exotoxin-
encoding gene content, as reported by Holtfreter et al. [20].
One reason for this diversity might be that CC8 is a large
and diverse CC, consisting of several successful clones. In
addition to the founder clone, ST8, several STs have diversi-
ﬁed to produce their own single-locus variants. One of these
successful clones is ST239, a clone with a mosaic chromo-
some consisting of ST8 and ST30 [21].
In cluster IV, and only in this cluster, we found the Euro-
pean CA-MRSA lineage, CC80 [22,23]. The presence of exo-
toxin-encoding genes in this cluster was uniform. LukS/F-PVL
and etd were present in all isolates, hla was present in 98.1%
of the isolates, and the remaining exotoxin-encoding genes
were absent. This lack of exotoxin-encoding genes is concor-
dant with earlier studies on ST80 [24]. The homogeneity in
the exotoxin-encoding gene content seems to be a unique
feature of the CC80 lineage, and could be a result of this
genetic lineage being less prone to accepting MGEs encoding
virulence genes through horizontal gene transfer. The ability
to restrict the entrance of foreign MGEs would separate the
lineage, with regard to exotoxin-encoding genes, from other
MRSA genetic lineages, and thus might be a reason why the
cluster analysis separated the CC in one cluster.
Cluster II consisted of isolates within CC8, ST8 and spa-
CC008. In the health region, there have been several out-
breaks at long-term-care facilities with isolates belonging to
TABLE 2. The distributions of the
exotoxin-encoding genes in the
cluster groupsExotoxin-
encoding
genes
Toxin cluster
group I
Toxin cluster
group II
Toxin cluster
group III
Toxin cluster
group IV
Present
(%)
Absent
(%)
Present
(%)
Absent
(%)
Present
(%)
Absent
(%)
Present
(%)
Absent
(%)
lucS/F-PVL 36.9 63.1 1.8 98.2 14.9 85.1 100 0
sea 30 70 97.3 2.7 7.3 92.7 0 100
seb 20.2 79.8 0 100 0.9 99.1 0 100
sec 2.4 97.6 0 100 23.1 76.9 0 100
sed 0 100 100 0 13.9 86.1 0 100
seg 0 100 0 100 100 0 0 100
sei 0 100 0 100 99.4 0.6 0 100
sej 0 100 100 0 16.1 83.9 0 100
eta 4.2 95.8 0 100 0 100 0 100
etd 0.3 99.7 0 100 0 100 100 0
hla 94.1 5.9 100 0 99.7 0.3 98.1 1.9
tst 0.3 99.7 0 100 16.1 83.9 0 100
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ST8-IV and spa-CC008. It is therefore possible that the clone
was over-represented in our MRSA database, which could
inﬂuence the cluster analysis. The exotoxin-encoding gene
content in cluster II was almost as homogeneous as that in
cluster IV, with only lukS/F-PVL and sea not having 100%
presence or absence. The exotoxin-encoding genes present
were lukS/F-PVL, sea, sed, sej, and hla.
In cluster I, CC8 was the largest CC, and the majority of
the isolates in CC8 were identical, on the ST, SCCmec and
spa-CC level, to the isolates in cluster II, but the cluster
analysis split these isolates into two clusters, where the lukS/
F-PVL-positive isolates were gathered in one cluster and the
negative isolates in a second cluster. In cluster I, the majority
of the ST8-IV and spa-CC008 isolates contained lukS/F-PVL
and hla, compatible with the ST8:USA300 clone. In cluster II,
the majority of the isolates did not harbour lukS/F-PVL, but
did harbour sed, sej, and hla. Diep et al. [25] found that
strains belonging to the ST8 lineage possessed similar viru-
lence gene repertoires. The discrepancy between our results
and those of Diep et al. might have resulted from our exam-
ining fewer determinants. Among the other genetic lineages
found in cluster I, both HA-MRSA and CA-MRSA clonal
lineages were represented (Table 3).
On the basis of genetic lineages and the number of lukS/
F-PVL-positive isolates, we propose that a majority of
CA-MRSA genetic lineages were grouped in cluster I according
to a similar exotoxin-encoding gene repertoire, and that this
repertoire is shared with some HA-MRSA lineages. The pres-
ence of exotoxin-encoding genes in cluster I was relatively
low. Eight of the 12 exotoxin-encoding genes were repre-
sented in less than 5% of the isolates, with four being absent.
The CA-MRSA clonal lineages thus seem to be found in clus-
ters with a low prevalence of exotoxin-encoding genes, with
only one exception, the Oceania clone ST30-IV, present in
cluster III.
Cluster III was represented by four large and three small
CCs, and major pandemic and epidemic HA-MRSA clones
were present (Table 3). This cluster contained the highest
percentage of exotoxin-encoding genes, but lukS/F-PVL was
primarily found in the Oceania clone. Most of the pandemic
and epidemic HA-MRSA clones were clustered together on
TABLE 3. Methicillin-resistant Staphylococcus aureus genetic
lineages (deﬁned by clonal complex (CC), sequence type
(ST), staphylococcal cassette chromosome mec (SCCmec)
type, and spa-CC) in the four toxin cluster groups
Cluster
group (n) CC (n) Spa-CCb (n) ST-SCCmecc
I (287) 1 (10) 127 (9) 1-IV, 474-V, 891-IV, 993-IV
S (1) 1-IV
5 (1) 062 (1) 5-IV
8 (204) 008 (135) 8-IV, 8-mecA, 8-V, 94-IV, 112-I,
113-IV, 247-I, 254-I, 449-IV,
824-I, 995-IV, 999-IV
012 (69) 110-mecA, 239-III, 241-III,
368-III, 592-III, 996-III
9 (1) S (1) 834-IV
12 (5) 012 (5) 12-IV
15 (1) S (1) 15-ccrC
45 (1) 216 (1) 45-IV
59 (20) 216 (20) 59-IV, 59-V, 338-V, 375-IV
88 (22) 186 (22) 88-IV, 825-IV, 859-IV
97 (1) S (1) 97-IV
228 (1) 002 (1) 228-I
398 (1) S (1) 398-V
509 (1) S (1) 207-V
913 (1) E (1) 913-V
d140a (2) NF (2) 140-IV
d152a (14) 355 (14) 152-V
d154a (1) 639 (1) 154-IV
II (110) 8 (110) 008 (110) 8-IV, 8-V, 8-C2mec
III (316) 1 (1) S (1) 772-V
5 (113) 002 (103) 5-I, 5-II, 5-IV, 5-V, 105-II, 114-II,
125-IV, 146-IV, 149-IV, 225-II,
231-II, 823-II, 826-IV, 998-IV
062 (4) 5-I, 5-II, 5-IV
E (2) 5-IV
8 (10) 012 (1) 239-III
148 (8) 72-IV, 72-V
S (1) 72-IV
22 (39) 022/032 (38) 22-IV
E (1) 22-IV
30 (77) 012 (70) 30-IV, 36-II, 37-IV
S (4) 30-IV, 39-II
E (3) 30-IV
45 (71) 065 (9) 45-IV
015/116 (35) 45-IV, 45-V, 820-IV
722/102 (18) 45-IV, 108-IV, 882-IV
E (9) 45-IV, 45-ccrC, 45-NT, 46-IV
228 (5) 002 (5) 111-I, 228-I
IV (108) 80 (108) 639 (106) 80-IV, 822-IV, 994-IV, 997-IV
NT (1) 80-IV
E (1) 80-IV
aNo predicted founder could be found using eBURST v/3.
bS, singleton (no related spa type could be found using BURP); E, excluded (the
spa sequence contained fewer than ﬁve repeats and was excluded from the
BURP analyses); NF, related spa types but no predicted founder could be estab-
lished using BURP; NT, non-typeable.
cC2mec, only the C2 mec complex could be found; mecA, only the mec-
complex A could be found; ccrC, only the ccr complex C could be found; NT,
non-typeable.
TABLE 4. Distribution of exotoxin-encoding genes within
the methicillin-resistant Staphylococcus aureus (MRSA)
genetic lineages (deﬁned by clonal complex (CC), or
sequence type (ST) if no CC could be found) discovered in
Health Region East, Norway
Exotoxin-encoding
gene Genetic lineage
sea CC1, CC5, CC8, CC30, CC59, CC228
seb CC5, CC8, CC12, CC59
sec CC1, CC5, CC8, CC9, CC22, CC30, CC45, ST154
sed CC5, CC8
seg CC1, CC5, CC8, CC22, CC30, CC45, CC228,
sei CC1, CC5, CC8, CC22, CC30, CC45, CC228,
sej CC5, CC8, CC45
eta CC88, CC913
etd CC80, CC913
tst CC5, CC8, CC22, CC30, CC45
hla CC1, CC5, CC8, CC9, CC12, CC15, CC22, CC30,
CC45, CC59, CC80, CC88, CC97, CC228, CC398,
CC509, CC913, ST140, ST152, ST154
lukS/F-PVL CC1, CC5, CC8, CC9, CC30, CC59,
CC80, CC398, ST152, ST154
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the basis of their exotoxin-encoding gene content, and they
clustered with one large CA-MRSA clone.
All MRSA risk factors, as described by the US CDC
(http://www.cdc.gov), could not be identiﬁed in this study,
and this could have resulted in an overestimation of CA-
MRSA. This would not alter our main conclusions. The study
was bi-directional, retrospective from 1991 to 2004 and
prospective from 2005 to 2006. However, the criteria used
in primary care or in healthcare institutions for taking MRSA
samples were not inﬂuenced by the investigation taking place.
All MRSA isolates identiﬁed by the microbiological laborato-
ries were included, and we believe that the change in case
ascertainment has had a minimal inﬂuence on our results and
conclusions.
To conclude, we have demonstrated four MRSA toxin
clusters, based on a cluster analysis of the exotoxin-encoding
genes of 821 MRSA isolates. A few genetic lineages were
split into several clusters, supporting the theory of a certain
restriction in the movement of MGEs encoding virulence
genes among different genetic lineages. CA-MRSA clones
tended to group together in clusters deﬁned by a low preva-
lence of exotoxin-encoding genes, and HA-MRSA clones
tended to group together in clusters with a higher preva-
lence of exotoxin-encoding genes.
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